Response to Gomez et al.'s Letter to the Editor Regarding: "Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants".
Johnna Perdrizet, Emily Horn, Winniefer Nua, Judith Perez-Peralta, Jennifer Nailes, Jaime Santos, Anna Ong-Lim
Author Information
- Johnna Perdrizet: Global Health Economics and Outcomes Research, Pfizer Inc., 235 42nd Street, New York, NY, 10017, USA. johnna.perdrizet@pfizer.com. ORCID
- Emily Horn: Global Health Economics and Outcomes Research, Pfizer Inc., 235 42nd Street, New York, NY, 10017, USA. ORCID
- Winniefer Nua: Pfizer Inc., Makati City, Philippines.
- Judith Perez-Peralta: Pfizer Inc., Makati City, Philippines.
- Jennifer Nailes: Research Institute for the Health Sciences, University of the East Ramon Magsaysay Memorial Medical Center, Quezon City, Philippines. ORCID
- Jaime Santos: Infectious Diseases Section, Philippine Children's Medical Center, Quezon City, Philippines.
- Anna Ong-Lim: Infectious and Tropical Disease, Department of Pediatrics, College of Medicine-Philippine General Hospital, University of the Philippines, Manila, Philippines.
No abstract text available.
- Infect Dis Ther. 2018 Dec;7(4):539-543
[PMID: 30411203]
- Pathogens. 2020 Jan 22;9(2):
[PMID: 31979079]
- Hum Vaccin Immunother. 2019;15(3):572-574
[PMID: 30657407]
- Infect Dis Ther. 2021 Mar;10(1):507-520
[PMID: 33575966]
- Infect Dis Ther. 2020 Jun;9(2):305-324
[PMID: 32096144]
- Hum Vaccin Immunother. 2019;15(3):560-569
[PMID: 30156978]
- Expert Rev Pharmacoecon Outcomes Res. 2022 Jan;22(1):1-3
[PMID: 34569403]
- Hum Vaccin Immunother. 2021 Apr 3;17(4):1162-1172
[PMID: 32966176]
- Hum Vaccin Immunother. 2020 Jul 2;16(7):1719-1727
[PMID: 31951782]
- Infect Dis Ther. 2018 Sep;7(3):353-371
[PMID: 29934878]
- Hum Vaccin Immunother. 2022 Dec 31;18(1):1917237
[PMID: 33908816]
